基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 有机原料 酮类化合物 依达拉奉 1-苯基-3-甲基-5-吡唑啉酮(PMP)
  • aladdin 阿拉丁 E408892 1-苯基-3-甲基-5-吡唑啉酮(PMP) 89-25-8 10mM in DMSO

aladdin 阿拉丁 E408892 1-苯基-3-甲基-5-吡唑啉酮(PMP) 89-25-8 10mM in DMSO

Edaravone
89-25-8
475.90 1ml 起订
上海 更新日期:2024-04-22

上海阿拉丁生化科技股份有限公司

VIP1年
联系人:阿拉丁客服
手机:+86-18521732826 拨打
邮箱:market@aladdin-e.com

产品详情:

中文名称:
1-苯基-3-甲基-5-吡唑啉酮(PMP)
英文名称:
Edaravone
CAS号:
89-25-8
品牌:
阿拉丁
产地:
上海
保存条件:
-80℃储存
纯度规格:
10mM in DMSO
产品类别:
药靶配体 药靶配体
分子式:
C10H10N2O
分子量:
174.2
运输条件:
超低温冰袋运输
产品规格:
1ml
货号:
E408892
是否进口:

中文名:1-苯基-3-甲基-5-吡唑啉酮(PMP)

英文名:Edaravone

英文别名:MCI-186;3-methyl-1-phenyl-1H-pyrazol-5(4H)-one

纯度:10mM in DMSO

货号:E408892

包装:1ml

Cas号:89-25-8

存储温度:-80℃储存

产品介绍:

Information

Edaravone (MCI-186) is a novel potent free radical scavenger that has been clinically used to reduce the neuronal damage following ischemic stroke.
In vitro

Edaravone exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Edaravone provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Edaravone, which inhibits oxidation and enhances NO production derived from increased eNOS expression, may improve and conserve cerebral blood flow without peroxynitrite generation during reperfusion.

In vivo

Edaravone significantly reduces the infarct volume and improves the neurological deficit scores at 24 hours after reperfusion in mice brain. Edaravone markedly suppresses the accumulation of HNE-modified protein and 8-OHdG at the penumbra area during the early period after reperfusion and reduces microglial activation, iNOS expression, and nitrotyrosine formation at the late period. Edaravone attenuates renal function and pathologic findings significantly in rat kidney. Edaravone significantly reduces the generation of free radicals in the tubular cells indicated by dichlorodihydrofluorescein. Edaravone-treated animals shows significantly improved neurological outcome. Edaravone-treatment provides a significant reduction in the number of TUNEL-positive apoptotic cells, a decrease in Bax immunoreactivity and an increase in Bcl-2 expression within the peri-infarct area. Edaravone shows an excellent neuroprotective effect against ischemia/reperfusion brain injury through a Bax/Bcl-2 dependent anti-apoptotic mechanism.
Cell Data

cell lines:Bladder epithelial cell line T24, RT-4 transitional cell papilloma bladder cell line, 5637 primary carcinoma bladder cell line, HCT-116, MDAMB231, MCF7, HEK293, A549, SKOV3 and DU145

Concentrations:

Incubation Time:

Powder Purity:≥99%

查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/E408892.html


MCI-186;3-methyl-1-phenyl-1H-pyrazol-5(4H)-one

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (16年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

1-苯基-3-甲基-5-吡唑啉酮(PMP)相关厂家报价 更多

内容声明
拨打电话 立即询价